I. Case Overview

Caught in a dilemma between the long-standing habit of “publication-first” among university research teams and the legal threshold that novelty is destroyed once research results are disclosed, ZYIP deferred drafting. Instead, we conducted multiple rounds of academic-level discussions to fully grasp the research, and designed a timeline for the client: file the patent first, then publish the paper. In the end, this valuable scientific discovery was presented on academic platforms while secured with clear legal boundaries.

II. Case Details

1. Client Profile & Industry

A TCM anti-tumor research team from a top-tier Chinese university. Its findings are critical to the modernization of traditional Chinese medicine and the international academic influence of anti-tumor drug development.

2. Client Pain Points & Challenges

(1) The last mile of research commercialization: The team’s core discoveries, accumulated over years of investment, struggled to move out of the laboratory. They lacked a bridge that understands both academic language and IP legal boundaries. While strong in research, the team’s IP mindset was dominated by the “publication-first” principle. (2) Difficulties in drafting TCM composition patents: Active ingredients of TCM compositions are hard to categorize neatly, and few comparable precedents exist in the prior art, bringing huge uncertainty to patent drafting. (3) Conflict between academic publication and IP protection: The team had long-standing misunderstandings of IP rules. Early publication of findings would destroy novelty, causing many studies to miss the optimal filing window. (4) Formalistic patent services for academia: Previous service providers treated patent drafting as a routine task. The resulting claims were unintelligible to researchers and failed to reflect the true value of their work.

3. Solutions & Implementation

(1) Learn the research before drafting patents The ZYIP team did not rush to prepare documents. We held multiple academic discussions with researchers to sort out pharmacodynamic data, molecular mechanisms and formulation logic step by step, mastering the underlying science first.

(2) Extract core findings as the main protection thread Our team identified the core scientific discovery: the multi-modal cell death mechanism of the composition. We selected an application-focused protection theme, which stabilizes the claims and reserves room for subsequent formulation adjustments.

(3) Coordinated schedule for filing and publication To address the team’s top concern, we proactively formulated the workflow: patent filing prior to paper publication. This arrangement preserves academic output opportunities without compromising legal protection.

(4) Free the team to focus on experiments After the patent was published, the research team commented that they could safely proceed with follow-up experiments. For researchers, this peace of mind matters more than a simple patent certificate.

4. Deliverables & Outcomes

① Patent outcome: Application of a traditional Chinese medicine composition in preparing drugs for treating pancreatic cancer was successfully published. The application-centered claim layout defines clear legal boundaries for modern TCM anti-tumor research. ② Protection robustness: The application-focused protection theme directly tackles drafting challenges arising from unclassified active ingredients and limited precedents for TCM compositions. It safeguards claim stability while accommodating future formulation modifications. ③ High client recognition: The inventor praised ZYIP’s attorney: “Strong professional capability and great service attitude. You provided solid support for this patent application!” The research team also confirmed they could safely advance follow-up experiments after patent publication. ④ Academic and translational value: High-quality patent protection provided robust support for subsequent international academic publications. The team later shared this research at several international conferences. Clear patent boundaries also removed major barriers for cooperation with pharmaceutical enterprises and commercial development, accelerating clinical translation.

III. Case Significance

This case fully demonstrates ZYIP’s technical depth and client-oriented support for IP services in university research translation. When academic teams engage patent attorneys, they do not want perfunctory documents produced just to “check a box”. They want their research essence to be truly recognized and embedded into the patent — the greatest respect for researchers. The case proves ZYIP is capable of reconciling publication and IP protection. Valuable scientific discoveries will not be buried merely in papers; they can be converted into enforceable legal rights on the path toward industrialization and market application.